Morgans Reaffirms Their Hold Rating on Orora (ORRAF)
Did a A$616.6m Glass Impairment and Cautious FY27 Outlook Just Shift Orora’s (ASX:ORA) Investment Narrative?
Orora updates market on progress of ongoing on‑market share buy‑back
Orora (ORRAF) Gets a Hold from Citi
ORA: Strong Cans growth offset by Glass impairment; robust cash flow and disciplined capital management
Orora FY26 underlying NPAT falls 5.9% to $142.2 million; revenue rises 6.5% to $2.23 billion